iScience (Jul 2023)

Oligosymptomatic long-term carriers of SARS-CoV-2 display impaired innate resistance but increased high-affinity anti-spike antibodies

  • Elena Montes-Cobos,
  • Victoria C. Bastos,
  • Clarice Monteiro,
  • João C.R. de Freitas,
  • Heiny D.P. Fernandes,
  • Clarice S. Constancio,
  • Danielle A.S. Rodrigues,
  • Andreza M.D.S. Gama,
  • Vinicius M. Vidal,
  • Leticia S. Alves,
  • Laura Zalcberg-Renault,
  • Guilherme S. de Lira,
  • Victor A. Ota,
  • Carolina Caloba,
  • Luciana Conde,
  • Isabela C. Leitão,
  • Amilcar Tanuri,
  • Orlando D.C. Ferreira,
  • Renata M. Pereira,
  • André M. Vale,
  • Terezinha M. Castiñeiras,
  • Dominique Kaiserlian,
  • Juliana Echevarria-Lima,
  • Marcelo T. Bozza

Journal volume & issue
Vol. 26, no. 7
p. 107219

Abstract

Read online

Summary: The vast spectrum of clinical features of COVID-19 keeps challenging scientists and clinicians. Low resistance to infection might result in long-term viral persistence, but the underlying mechanisms remain unclear. Here, we studied the immune response of immunocompetent COVID-19 patients with prolonged SARS-CoV-2 infection by immunophenotyping, cytokine and serological analysis. Despite viral loads and symptoms comparable to regular mildly symptomatic patients, long-term carriers displayed weaker systemic IFN-I responses and fewer circulating pDCs and NK cells at disease onset. Type 1 cytokines remained low, while type-3 cytokines were in turn enhanced. Of interest, we observed no defects in antigen-specific cytotoxic T cell responses, and circulating antibodies displayed higher affinity against different variants of SARS-CoV-2 Spike protein in these patients. The identification of distinct immune responses in long-term carriers adds up to our understanding of essential host protective mechanisms to ensure tissue damage control despite prolonged viral infection.

Keywords